Guangdong Biolight Meditech Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 4.89%

Guangdong Biolight Meditech Co Ltd (300246) has an Asset Resilience Ratio of 4.89% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥120.25 Million

≈ $17.60 Million USD Cash + Short-term Investments

Total Assets

CN¥2.46 Billion

≈ $359.82 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how Guangdong Biolight Meditech Co Ltd's Asset Resilience Ratio has changed over time. Check how strategically is Guangdong Biolight Meditech Co Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Guangdong Biolight Meditech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300246 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥120.25 Million	4.89%
Total Liquid Assets	CN¥120.25 Million	4.89%

Asset Resilience Insights

Limited Liquidity: Guangdong Biolight Meditech Co Ltd maintains only 4.89% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Guangdong Biolight Meditech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Guangdong Biolight Meditech Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Bio-Rad Laboratories Inc NYSE:BIO	Medical Devices	10.80%
Double Medical Technology Inc SHE:002901	Medical Devices	12.59%
Tellgen Corp SHE:300642	Medical Devices	9.96%
Affluent Medical SAS PA:AFME	Medical Devices	0.03%
Cochlear Ltd AU:COH	Medical Devices	9.76%
Anteris Technologies Global Corp AU:AVR	Medical Devices	33.27%
Imricor Medical Systems Inc AU:IMR	Medical Devices	46.50%
Polynovo Ltd AU:PNV	Medical Devices	0.04%

Annual Asset Resilience Ratio for Guangdong Biolight Meditech Co Ltd (2015–2024)

The table below shows the annual Asset Resilience Ratio data for Guangdong Biolight Meditech Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	10.56%	CN¥263.97 Million ≈ $38.63 Million	CN¥2.50 Billion ≈ $365.66 Million	+7.32pp
2020-12-31	3.25%	CN¥52.20 Million ≈ $7.64 Million	CN¥1.61 Billion ≈ $235.18 Million	+0.13pp
2019-12-31	3.12%	CN¥30.00 Million ≈ $4.39 Million	CN¥961.46 Million ≈ $140.69 Million	+2.25pp
2016-12-31	0.87%	CN¥6.00 Million ≈ $877.99K	CN¥686.57 Million ≈ $100.47 Million	+0.19pp
2015-12-31	0.69%	CN¥4.00 Million ≈ $585.33K	CN¥580.65 Million ≈ $84.97 Million	--

pp = percentage points

About Guangdong Biolight Meditech Co Ltd

SHE:300246 China Medical Devices

Market Cap

$745.75 Million

CN¥5.10 Billion CNY

Market Cap Rank

#10055 Global

#2594 in China

Share Price

CN¥19.26

Change (1 day)

+10.37%

52-Week Range

CN¥7.83 - CN¥21.57

All Time High

CN¥30.12